We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Flexible-Fiber CO2 Laser Useful in Transsphenoidal Surgery

By HospiMedica International staff writers
Posted on 29 Aug 2011
A new study demonstrates that flexible-fiber CO2 laser can safely cut and coagulate during endoscopic assisted transsphenoidal craniotomies (TSC), without the line-of-sight problems encountered with conventional CO2 lasers. More...


Researchers at Boston Medical Center (BMC; MA, USA) and Boston University School of Medicine (BUSM; MA, USA) conducted a retrospective chart review to review the utility and safety of the flexible-fiber CO2 laser in TSC surgery. In all, 16 patients were identified who underwent the laser-assisted procedure; all tumor pathology types were considered. Results were assessed based on hormone status, tumor size, pathology, complications, and resection rates.

The results showed that 16 pituitary lesions with an average size of 22.7 mm were identified by radiographic and pathologic criteria. All patients underwent flexible-fiber CO2 laser-assisted endoscopic endonasal TSC surgery. Gross total resection was achieved in 7 of 16 patients (43.75%) with hormone remission in all patients after a mean follow-up of 19.3 months. Postoperative complications occurred in three patients (18.75%), of which two patients developed transient diabetes insipidus (DI) and one developed a cerebrospinal fluid (CSF) leak requiring surgical repair. Five patients (31.25%) underwent postoperative radiation to the residual lesions. The study was published in the July/August 2011 issue of World Neurosurgery.

“Because most pituitary tumors are soft, the CO2 laser was not used extensively for tumor resection in this series, but we have found it very helpful in removing recurrent pituitary adenomas where tumor consistency is often more fibrous, and dural scarring may be extensive,” said study coauthor author Anand Devaiah, MD, an associate professor of otolaryngology and neurological surgery at BUSM.

The implementation of endoscopy in transsphenoidal surgery for pituitary tumors and other sellar lesions has been bolstered by the demonstration of its safety and relative advantages over traditional microscope-based approaches. The long wavelength of the CO2 laser has been demonstrated to have high absorption in tissue and water, with rapid conversion of light energy into heat within a small volume of tissue. This property makes the CO2 laser an excellent cutting and ablation tool, because it causes minimal thermal damage to adjacent tissue.

Related Links:

Boston Medical Center
Boston University School of Medicine




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.